Turquoise
Health

Ask an American what their MRI will cost and watch the silence. Not because the answer is complicated - because, until recently, the answer did not exist anywhere a normal person could reach it. Turquoise Health was built on the suspicion that this silence was a choice, not a law of nature. The company spends its days dragging the price of your knee surgery out into daylight, one machine-readable file at a time.

Who they are now

San Diego, present day

Turquoise Health calls itself the operating system for healthcare contracts and payments, which is a grand phrase for a deeply unglamorous job: making sense of what things cost. The company takes the pricing data that hospitals and insurers are now required to publish - dense, near-unreadable files that almost nobody opens - and turns it into something a contracting team can actually use. In March 2026 it raised a $40 million Series C, bringing its total to $95 million, and put a flag in the ground. It no longer wants to be a data vendor that reports prices. It wants to sit inside the transaction itself.

More than 280 organizations now run on the platform. That list includes 10 of the top 25 health systems, 4 of the 5 national payers, 9 of the top 10 pharmaceutical companies, and 6 of the top 10 insurance brokers. For a company that started by scraping hospital websites, that is a strange and rapid kind of legitimacy.

The problem they saw

The most expensive secret in America

Here is the tension that runs under everything Turquoise does. In almost every other market, you learn the price before you buy. Healthcare reversed the order. You receive the care, then you wait weeks for a number that nobody - not you, not the front desk, sometimes not even the billing department - could have told you in advance. Families have gone into debt over a transaction that was broken by design.

Chris Severn learned this the slow way. Before Turquoise he founded Arcosta, a machine-learning company aimed at hospital revenue cycle and operations, which is a polite way of saying he spent years in the trenches of appeals and billing battles. He watched the same dysfunction repeat: prices hidden, contracts buried, everyone guessing. The federal price transparency rule, which took effect in 2021, was supposed to fix this by forcing hospitals and payers to publish their rates. It did - technically. The files were published. They were also enormous, inconsistent, and effectively unreadable.

The founders' bet

Two people, one stubborn idea

Severn teamed up with Adam Geitgey, a software engineer with a long track record in machine learning, who became Turquoise's CTO and the technical mind behind the product. Their bet, made in 2020, was contrarian in the way good bets usually are: while lawyers were still arguing about whether the transparency rule would survive, the two founders followed the legal fight, decided the rule was here to stay, and started building before the dust settled.

By January 17, 2021 - within weeks of the rule taking effect - they had aggregated and published pricing data from roughly 1,200 hospitals. Not a pilot. Not a slide. A working, searchable starting point for comparing the cost of care. The wager was simple: be early, be useful, and let everyone else catch up to the idea that prices should be knowable.

CAPTION: Two founders who read a 300-page federal rule for fun and saw a company in the footnotes. Most people saw a PDF.

The product

Three layers, one legible price

The platform now stands on three products that build on each other. Clear Rates is the foundation: it synthesizes machine-readable files, claims data, Medicare benchmarks, and every other relevant pricing signal into a single, auditable rate for each payer-provider combination. Instead of a thousand conflicting numbers, you get one - and you can see how it was built.

Clear Contracts goes after the paper. It uses AI to tag every rate and provision across a customer's contract portfolio, turning static, filed-away documents into something dynamic - a place where teams can find a clause, compare how a contract is actually performing, and model what a renegotiation would do, in a few clicks rather than a few weeks. Woven across all of it is AskTQ, an AI pricing-and-contracting layer that compresses research that used to take weeks into seconds.

The proof

Numbers that argue the case

Skeptics are right to ask whether any of this actually lands. The adoption numbers are the strongest answer Turquoise has. When most of the national payers, a third of the top health systems, and nearly every major pharmaceutical company are running their pricing through one platform, the thing has stopped being a clever tool and started being infrastructure. Named customers include UNC Health, Loma Linda University Health, Banner Health, HonorHealth, Quest Diagnostics, Merck, and Aon.

CAPTION: Each round bigger than the last, which in venture math means people increasingly believe you can charge for clarity. The boring chart is the bullish one.

The mission

A waste-free transaction

Turquoise frames its purpose around a single idea: a waste-free healthcare transaction. The vision the team describes is one where standardized pricing and aligned contracts dissolve the administrative friction that sits between a patient and a paid bill - to the point where same-day, transparent payment becomes normal rather than miraculous. It is less a moonshot than a demand that healthcare behave like every other industry that figured out how to tell you the price first.

That is also why the Series C language shifted from transparency to payments. Knowing the price is step one. Actually paying it cleanly, quickly, without a month of guessing - that is the part Turquoise is now building toward. Backers like Oak HC/FT, who led the round, are betting that embedding transparency into the negotiation and payment workflow is worth more than selling the data on the side.

Why it matters tomorrow

The wager, restated

The skeptical reading is fair: transparency has been promised before, and American healthcare has a talent for absorbing reform without changing much. Turquoise's answer is not a slogan but a position. It has quietly become the layer where rates and contracts are reconciled for a large share of the industry. If healthcare payments do modernize this decade, the rails are likelier to run through a company like this than around it.

There is a tidy irony in the fact that the most radical thing a healthcare company can do in 2026 is tell you what something costs before you buy it. Turquoise did not invent that idea. It just refused to accept that medicine was exempt from it.

So, back to the MRI. Ask an American what it will cost, and the silence is starting to break. Somewhere a contracting team pulls up a single auditable rate, a patient sees a number before the appointment, and the bill - for once - holds no surprises. That is the whole company, in one boring, revolutionary sentence: the price came first.

Profile compiled from public sources, March 2026. Figures are as reported by the company and press; funding and customer counts are point-in-time and approximate.